Literature DB >> 21277609

Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus.

Sara E Woodson1, Alexander N Freiberg, Michael R Holbrook.   

Abstract

Wild-type yellow fever virus (YFV) infections result in a hepatotropic disease which is often fatal, while vaccination with the live-attenuated 17-D strain results in productive infection yet is well-tolerated with few adverse events. Kupffer cells (KCs) are resident liver macrophages that have a significant role in pathogen detection, clearance and immune signaling. Although KCs appear to be an important component of YF disease, their role has been under-studied. This study examined cytokine responses in KCs following infection with either wild-type or vaccine strains of YFV. Results indicate that KCs support replication of both wild-type and vaccine strains, yet wild-type YFV induced a prominent and prolonged pro-inflammatory cytokine response (IL-8, TNF-α and RANTES/CCL5) with little control by a major anti-inflammatory cytokine (IL-10). This response was significantly reduced in vaccine strain infections. These data suggest that a differentially regulated infection in KCs may play a critical role in development of disease.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277609     DOI: 10.1016/j.virol.2011.01.012

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Experimental therapies for yellow fever.

Authors:  Justin G Julander
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

2.  Immune tolerance in liver disease.

Authors:  Ian N Crispe
Journal:  Hepatology       Date:  2014-09-26       Impact factor: 17.425

Review 3.  Yellow Fever Virus: Knowledge Gaps Impeding the Fight Against an Old Foe.

Authors:  Florian Douam; Alexander Ploss
Journal:  Trends Microbiol       Date:  2018-06-19       Impact factor: 17.079

4.  Pathophysiologic and transcriptomic analyses of viscerotropic yellow fever in a rhesus macaque model.

Authors:  Flora Engelmann; Laurence Josset; Thomas Girke; Byung Park; Alex Barron; Jesse Dewane; Erika Hammarlund; Anne Lewis; Michael K Axthelm; Mark K Slifka; Ilhem Messaoudi
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 5.  Historical Perspectives on Flavivirus Research.

Authors:  Michael R Holbrook
Journal:  Viruses       Date:  2017-04-30       Impact factor: 5.048

Review 6.  What Does the Future Hold for Yellow Fever Virus? (II).

Authors:  Raphaëlle Klitting; Carlo Fischer; Jan F Drexler; Ernest A Gould; David Roiz; Christophe Paupy; Xavier de Lamballerie
Journal:  Genes (Basel)       Date:  2018-08-21       Impact factor: 4.096

7.  The Usefulness of a Duplex RT-qPCR during the Recent Yellow Fever Brazilian Epidemic: Surveillance of Vaccine Adverse Events, Epizootics and Vectors.

Authors:  Alice L N Queiroz; Rafael S Barros; Sandro P Silva; Daniela S G Rodrigues; Ana C R Cruz; Flávia B Dos Santos; Pedro F C Vasconcelos; Robert B Tesh; Bruno T D Nunes; Daniele B A Medeiros
Journal:  Pathogens       Date:  2021-06-03

8.  Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells.

Authors:  Yu Cong; Monica A McArthur; Melanie Cohen; Peter B Jahrling; Krisztina B Janosko; Nicole Josleyn; Kai Kang; Tengfei Zhang; Michael R Holbrook
Journal:  PLoS Negl Trop Dis       Date:  2016-05-18

Review 9.  Humanized Mice for Live-Attenuated Vaccine Research: From Unmet Potential to New Promises.

Authors:  Aoife K O'Connell; Florian Douam
Journal:  Vaccines (Basel)       Date:  2020-01-21

10.  Yellow Fever Vaccination in a Mouse Model Is Associated With Uninterrupted Pregnancies and Viable Neonates Except When Administered at Implantation Period.

Authors:  Fernanda C da Silva; Fernanda M Magaldi; Helena K Sato; Estela Bevilacqua
Journal:  Front Microbiol       Date:  2020-02-20       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.